Top Story

Enrollment on genomically matched clinical trials improves sarcoma outcomes

Enrollment on genomically matched clinical trials improves sarcoma outcomes
July 17, 2019
In the Journals

Race/ethnicity, socioeconomic status associated with increased risk for death among young cancer survivors

July 17, 2019
Non-Latino white adolescents and young adults who are cancer survivors have a lower risk for subsequent death compared with survivors of other races and ethnicities…
Meeting NewsVideo

VIDEO: Intensity Therapeutics’ intratumoral formulation active in highly refractory cancers

June 26, 2019
CHICAGO — Lewis H. Bender, MS, MA, MBA, founder, president and CEO of Intensity Therapeutics, spoke with HemOnc Today at ASCO Annual Meeting about preliminary…

ASCO Annual Meeting: I got plenary of nothing!

HemOnc Today, June 25, 2019
Derek Raghavan, MD, PhD
Here we are, back from another bigger, better, more extreme ASCO Annual Meeting. Every year, about this time, I return from what is billed as the biggest and best cancer…
More Headlines »

2019 Texas Oncology Clinical Educational Symposium

This activity is supported by educational grants from AbbVie, Inc.; Celgene Corporation; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.; Takeda Oncology; and Verastem, Inc..

Clinical outcomes for advanced cancers continue to improve through the identification as well as the development of…
More »
Meeting News

VIDEO: Studies in lung cancer, sarcoma highlight Eli Lilly presentations at ASCO

June 20, 2019
More »

Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board

This activity is supported by an educational grant from Merck & Co., Inc.

The treatment paradigm for the management of patients with advanced cancer has changed dramatically within recent years…
More »